CONTINGENT PAYMENT (Details Narrative) |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
USD ($)
| |
| CONTINGENT PAYMENT | |
| Net sales and profit sharing | $ 400,000 |
| Upfront purchase price | $ 400,000 |
| Seller for purchase of assets description | on March 4, 2025, the Company shall pay upfront purchase price of $400,000 via Seller’s retention, until such amounts equal $400,000 of 50% of the Net Sales (as defined in the APA) of Lucemyra and 50% of the Net Distributable Profits (as defined in the APA) of the generic version of Lucemyra. The Company shall also pay to the Seller a royalty equal to 3% of the Net Sales of Lucemyra and 3% of the Net Distributable Profits of the generic version of Lucemyra on a calendar quarter basis. Royalty payments shall commence on the date of the acquisition |
| Royalty payments period | 5 years |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A description of the transaction and the assets involved in the sale of property to another party and the lease of the property back to the seller. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|